Show simple item record

The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO

dc.contributor.authorCollins, Pen_US
dc.contributor.authorChalmers, Een_US
dc.contributor.authorChowdary, Pen_US
dc.contributor.authorKeeling, Den_US
dc.contributor.authorMathias, Men_US
dc.contributor.authorO'Donnell, Jen_US
dc.contributor.authorPasi, KJen_US
dc.contributor.authorRangarajan, Sen_US
dc.contributor.authorThomas, Aen_US
dc.date.accessioned2016-07-20T10:58:10Z
dc.date.available2016-05-12en_US
dc.date.issued2016-07en_US
dc.date.submitted2016-06-21T11:41:48.203Z
dc.identifier.issn1351-8216en_US
dc.identifier.other10.1111/hae.13013
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/13576
dc.format.extent487 - 498en_US
dc.language.isoenen_US
dc.relation.ispartofHAEMOPHILIAen_US
dc.subjectcoagulation factor concentratesen_US
dc.subjectenhanced half-lifeen_US
dc.subjectpharmacokineticsen_US
dc.subjectprophylaxisen_US
dc.titleThe use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDOen_US
dc.typeArticle
dc.rights.holder2016 John Wiley & Sons Ltd
dc.identifier.doi10.1111/hae.13013en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000387387000026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.issue4en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume22en_US


Files in this item

Thumbnail
Name:
UKHCDO long acting guidance ...
Size:
392.5Kb
Format:
application/
Description:
Submitted version
View/Open

This item appears in the following Collection(s)

Show simple item record